U.S. markets open in 7 hours 54 minutes
  • S&P Futures

    3,450.50
    +18.25 (+0.53%)
     
  • Dow Futures

    28,315.00
    +133.00 (+0.47%)
     
  • Nasdaq Futures

    11,713.50
    +52.75 (+0.45%)
     
  • Russell 2000 Futures

    1,625.20
    +10.40 (+0.64%)
     
  • Crude Oil

    41.42
    -0.28 (-0.67%)
     
  • Gold

    1,920.20
    +4.80 (+0.25%)
     
  • Silver

    25.15
    +0.17 (+0.68%)
     
  • EUR/USD

    1.1848
    +0.0020 (+0.17%)
     
  • 10-Yr Bond

    0.7970
    0.0000 (0.00%)
     
  • Vix

    29.35
    +0.17 (+0.58%)
     
  • GBP/USD

    1.2973
    +0.0026 (+0.20%)
     
  • USD/JPY

    105.3170
    -0.1530 (-0.15%)
     
  • BTC-USD

    12,233.43
    +1,176.42 (+10.64%)
     
  • CMC Crypto 200

    245.76
    +6.85 (+2.87%)
     
  • FTSE 100

    5,889.22
    +4.57 (+0.08%)
     
  • Nikkei 225

    23,664.43
    +97.39 (+0.41%)
     

Rafarma Establishes Thailand Corporate Entity For Merger and Expansion Projects

RAFARMA PHARMACEUTICALS INC
·1 min read

Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is registered under the name of RAFARMA (THAILAND) CO., LTD. The Company intends to use the business entity for entering into new association agreements with Thai universities. New association agreements are currently under negotiations and are expected to cover research and joint projects in production of cannabis based products. Also, in the light of recent agreement with R. & D. BIOCOGENCY LABORATORIES GROUP, the Company will use the new entity to conduct clinical trials and license its new products in Thailand for future distribution in South-East Asian markets.

For more information, contact:

RAFARMA
(307) 429-2029